Abrams jeffrey j - direct investment history in Imprimis pharmaceuticals inc

Filed on 2013-07-01 by Abrams Jeffrey J SEC CIK 1421168 Form 4

Accession 0001078782-13-001289.txt Sec File: edgar/data/1421168/0001078782-13-001289-index.htm

2013-06-27 Abrams Jeffrey J (CIK 1421168) through Direct

Invested in Imprimis Pharmaceuticals Inc bought 6865 shares remaining shares owned 45927

Common Stock Imprimis Pharmaceuticals Inc Immy Transaction code: A Grant, award, or other acquisition

f1 award of restricted stock units vests in full on the thirteen month anniversary of the date of grant. the shares underlying such restricted stock units will not be delivered to the reporting person and may not be transferred or sold until the termination of service.
f2 not applicable.


Filed on 2012-04-27 by Abrams Jeffrey J SEC CIK 1421168 Form 4

Accession 0001421168-12-000003.txt Sec File: edgar/data/1421168/0001421168-12-000003-index.htm

2012-04-01 Abrams Jeffrey J (CIK 1421168) through Direct

Invested in Imprimis Pharmaceuticals Inc bought 125000 shares at $0 remaining shares owned 436250

Option Right To Buy Imprimis Pharmaceuticals Inc Immy exercise date 2012-04-01 exercise price 0.9 has valueitem expiration due date 2017-03-31 underlying security shares 125000 underlying security title Common Stock

f2 the stock options, granted on april 1, 2012, were granted pursuant to the issuer's 2007 stock incentive and awards plan. mr. abram's options maintain a strike price of $0.90, and vest quarterly over a one year term with the initial 31,250 options vesting on june 30, 2012, the next 31,250 options vesting on september 30, 2012, the next 31,250 options vesting on december 31, 2012 and the final 31,250 options vesting on march 31, 2013.


Filed on 2012-04-27 by Abrams Jeffrey J SEC CIK 1421168 Form 4

Accession 0001421168-12-000003.txt Sec File: edgar/data/1421168/0001421168-12-000003-index.htm

2012-04-01 Abrams Jeffrey J (CIK 1421168) through Direct

Invested in Imprimis Pharmaceuticals Inc bought 300000 shares at $0 remaining shares owned 311250

Option Right To Buy Imprimis Pharmaceuticals Inc Immy exercise date 2012-04-01 exercise price 0.9 has valueitem expiration due date 2022-03-31 underlying security shares 300000 underlying security title Common Stock

f1 the stock options, granted on april 1, 2012, were granted pursuant to the issuer's 2007 stock incentive and awards plan. mr. abram's options vest over a 1 year period at a strike price of $0.90, with 25,000 options vesting monthly for the next twelve month period. as of the date of this form 3 filing, options to purchase 50,000 shares of the issuer's common stock are exercisable, but no options have been exercised.